Biomed International

Biomed International company information, Employees & Contact Information

BioMED Pharmaceutical Industries was founded in 2014 and specializes in the manufacture of healthcare products. We launched our first product in 2014 and have continued to expand our product line over the years. We now offer more than 100 products across 10 therapeutic lines, all designed to improve the quality of life for patients. In 2015, BioMED received its final license for our manufacturing plant, which allowed us to ramp up production and meet the increasing demand for our products. We now have three manufacturing plants, which enables us to produce a wide range of healthcare products for a variety of different indications. About Us “A better life, BioMED’s pledge” BioMED, a pharmaceutical company based in Egypt, specializes in the production of a wide range of pharmaceutical products, including generic and innovative drugs, as well as medical and healthcare products. BioMed, have a strong presence in the domestic market and established international partnerships and distribution networks in many countries around the world. Our dedication lies in providing high-quality, affordable healthcare solutions and we have a strong focus on research and development. BioMED is a leading player in the global pharmaceutical industries and is well-positioned for continued growth and success in the future. Our MISSION “pledge for a better life”: to make a pledge to healthcare providers, society, patients, families, and individuals to improve healthcare and promote a better quality of life through the development and provision of innovative products and services. Our VISION “Our commitment to quality and professionalism” BioMED pledges to become one of the top 20 pharmaceutical companies in Egypt by the end of 2023. We pledge to focus on penetrating the international market and to meet the challenges of operating as a multinational company in the coming decade. Our belief is that, through consistently maintaining high performance levels we can achieve our vision

Company Details

Employees
42
Founded
-
Address
34 - Nada Compound - 1st Settlement - New Cairo, Building,egypt
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
New Cairo, Cairo
Looking for a particular Biomed International employee's phone or email?

Biomed International Questions

News

Harbour BioMed partners with Otsuka on new T-cell therapy - Pharmaceutical Technology

Harbour BioMed partners with Otsuka on new T-cell therapy Pharmaceutical Technology

Biomed Pharma Inc. marks 15 years with new office in Malate - CinemaBravo

Biomed Pharma Inc. marks 15 years with new office in Malate CinemaBravo

Govt warns pharma exporters of payment delays from Egypt firm Biomed - Mint

Govt warns pharma exporters of payment delays from Egypt firm Biomed Mint

Harbour BioMed, Otsuka Partner to Advance Bispecific T-Cell Engagers - Contract Pharma

Harbour BioMed, Otsuka Partner to Advance Bispecific T-Cell Engagers Contract Pharma

Gilead licenses Hanmi’s encequidar for global virology in $34.5 mil deal - koreabiomed.com

Gilead licenses Hanmi’s encequidar for global virology in $34.5 mil deal koreabiomed.com

BioMed X and Novo Nordisk launch collaboration on oral peptide drug delivery - Express Pharma

BioMed X and Novo Nordisk launch collaboration on oral peptide drug delivery Express Pharma

Harbour BioMed Launches Élancé Therapeutics - Contract Pharma

Harbour BioMed Launches Élancé Therapeutics Contract Pharma

JW Pharm’s net profit soared 76% despite R&D increase last year - koreabiomed.com

JW Pharm’s net profit soared 76% despite R&D increase last year koreabiomed.com

Tuas Biomedical Park - Home | JTC

Tuas Biomedical Park Home | JTC

Research and development - Novartis

Research and development Novartis

Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields - Frontiers

Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields Frontiers

Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game - Yahoo Finance

Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game Yahoo Finance

German research institute launches program to match threatened NIH grants with pharma funders - Fierce Biotech

German research institute launches program to match threatened NIH grants with pharma funders Fierce Biotech

Implications of analytical nanoscience in pharmaceutical and biomedical fields: A critical view - ScienceDirect.com

Implications of analytical nanoscience in pharmaceutical and biomedical fields: A critical view ScienceDirect.com

BioMed X and Novo Nordisk collaborate on oral peptide drug delivery - The Pharma Letter

BioMed X and Novo Nordisk collaborate on oral peptide drug delivery The Pharma Letter

Mainz Biomed Vs. Aurinia Pharma: Retail Traders Weigh In On The Better Biotech Bet - MSN

Mainz Biomed Vs. Aurinia Pharma: Retail Traders Weigh In On The Better Biotech Bet MSN

Harbour BioMed Appoints Michael D. Patten Chief Strategy Officer - Contract Pharma

Harbour BioMed Appoints Michael D. Patten Chief Strategy Officer Contract Pharma

Harbour BioMed & Insilico Partner on AI-Driven Antibody Discovery - Contract Pharma

Harbour BioMed & Insilico Partner on AI-Driven Antibody Discovery Contract Pharma

AI is most powerful tool for Korean pharma to close gap with global leaders: KPBMA - koreabiomed.com

AI is most powerful tool for Korean pharma to close gap with global leaders: KPBMA koreabiomed.com

The BioMed X Institute, Boehringer Ingelheim Launch Call for Research Proposals - Contract Pharma

The BioMed X Institute, Boehringer Ingelheim Launch Call for Research Proposals Contract Pharma

Vector BioMed debuts as viral vector CDMO with $15M funding - Fierce Pharma

Vector BioMed debuts as viral vector CDMO with $15M funding Fierce Pharma

Otsuka signs $670M deal with Harbour for BCMAxCD3 bispecific - FirstWord Pharma

Otsuka signs $670M deal with Harbour for BCMAxCD3 bispecific FirstWord Pharma

Catastrophic pharmaceutical expenditure in patients with type 2 diabetes in Iran - International Journal for Equity in Health

Catastrophic pharmaceutical expenditure in patients with type 2 diabetes in Iran International Journal for Equity in Health

Bayer’s AskBio teams up with China’s Belief BioMed - The Pharma Letter

Bayer’s AskBio teams up with China’s Belief BioMed The Pharma Letter

The digital transformation in pharmacy: embracing online platforms and the cosmeceutical paradigm shift - Journal of Health, Population and Nutrition

The digital transformation in pharmacy: embracing online platforms and the cosmeceutical paradigm shift Journal of Health, Population and Nutrition

Chitosan-tripolyphosphate nanoparticles designed to encapsulate polyphenolic compounds for biomedical and pharmaceutical applications − A review - ScienceDirect.com

Chitosan-tripolyphosphate nanoparticles designed to encapsulate polyphenolic compounds for biomedical and pharmaceutical applications − A review ScienceDirect.com

BioMed X and Novo Nordisk partner on oral peptide drug delivery innovation - Pharmafile

BioMed X and Novo Nordisk partner on oral peptide drug delivery innovation Pharmafile

J&J taps BioMed X for crowdsourced oral biologics delivery push - Fierce Pharma

J&J taps BioMed X for crowdsourced oral biologics delivery push Fierce Pharma

AstraZeneca bags rights to Harbour BioMed's bispecific targeting Claudin18.2, CD3 - FirstWord Pharma

AstraZeneca bags rights to Harbour BioMed's bispecific targeting Claudin18.2, CD3 FirstWord Pharma

Management of pharmaceutical waste from hospitals and community pharmacies in Bahir Dar and Gondar cities, Ethiopia - BMC Health Services Research

Management of pharmaceutical waste from hospitals and community pharmacies in Bahir Dar and Gondar cities, Ethiopia BMC Health Services Research

Agilent Technologies Inc. Acquires Avida Biomed - Contract Pharma

Agilent Technologies Inc. Acquires Avida Biomed Contract Pharma

DKSH Healthcare Korea eyes growth as flexible and capable partner: GM - koreabiomed.com

DKSH Healthcare Korea eyes growth as flexible and capable partner: GM koreabiomed.com

BioAgilytix Acquires Cambridge Biomedical - Contract Pharma

BioAgilytix Acquires Cambridge Biomedical Contract Pharma

The modern Russian pharmaceutical market: consumer attitudes towards distance retailing of medicines - BMC Health Services Research

The modern Russian pharmaceutical market: consumer attitudes towards distance retailing of medicines BMC Health Services Research

[JPM2025] D&D Pharmatech draws attention at JPM2025 following US partner’s Nasdaq listing - koreabiomed.com

[JPM2025] D&D Pharmatech draws attention at JPM2025 following US partner’s Nasdaq listing koreabiomed.com

10 biotechs to know in China - Fierce Pharma

10 biotechs to know in China Fierce Pharma

Celltrion ends Kern Pharma deal and begins direct sales of oncology biosimilars in Spain - koreabiomed.com

Celltrion ends Kern Pharma deal and begins direct sales of oncology biosimilars in Spain koreabiomed.com

Best Biotech Stocks to Buy in 2025 - The Motley Fool

Best Biotech Stocks to Buy in 2025 The Motley Fool

Japanese Pharma Giant Leases Entire 600K SF Lab Project In Kendall Square - Bisnow

Japanese Pharma Giant Leases Entire 600K SF Lab Project In Kendall Square Bisnow

SK biopharmaceuticals' Q1 earnings solid on strong US cenobamate sales - koreabiomed.com

SK biopharmaceuticals' Q1 earnings solid on strong US cenobamate sales koreabiomed.com

Merck KGaA and BioMed X launch new joint cancer research programme - PharmaTimes

Merck KGaA and BioMed X launch new joint cancer research programme PharmaTimes

(PDF) Recent applications of quantitative analytical FTIR spectroscopy in pharmaceutical, biomedical, and clinical fields: A brief review - researchgate.net

(PDF) Recent applications of quantitative analytical FTIR spectroscopy in pharmaceutical, biomedical, and clinical fields: A brief review researchgate.net

Adroit Biomed Ltd. Announces Innovative, Technologically Advanced, High-Performance Collagen 'Fortisil C' - ET HealthWorld

Adroit Biomed Ltd. Announces Innovative, Technologically Advanced, High-Performance Collagen 'Fortisil C' ET HealthWorld

GI Innovation nets European patent for allergy microbiome combo - koreabiomed.com

GI Innovation nets European patent for allergy microbiome combo koreabiomed.com

Category: J Pharma Biomed Anal - Retraction Watch

Category: J Pharma Biomed Anal Retraction Watch

Zuellig Pharma Korea in total capital erosion for 2 consecutive years - koreabiomed.com

Zuellig Pharma Korea in total capital erosion for 2 consecutive years koreabiomed.com

Singapore biomed production breaks out of slump, EDB says at least 1,000 new jobs in pipeline - Singapore Economic Development Board (EDB)

Singapore biomed production breaks out of slump, EDB says at least 1,000 new jobs in pipeline Singapore Economic Development Board (EDB)

(PDF) Carrageenan: Drug Delivery Systems and Other Biomedical Applications - researchgate.net

(PDF) Carrageenan: Drug Delivery Systems and Other Biomedical Applications researchgate.net

By tapping tech and innovation, this company is spearheading the pharma industry - YourStory.com

By tapping tech and innovation, this company is spearheading the pharma industry YourStory.com

(PDF) A Review of Natural Polysaccharides: Sources, Characteristics, Properties, Food and Pharmaceutical Applications - researchgate.net

(PDF) A Review of Natural Polysaccharides: Sources, Characteristics, Properties, Food and Pharmaceutical Applications researchgate.net

101 Top Medical Startups and Companies in Spain (2021) - EU-Startups

101 Top Medical Startups and Companies in Spain (2021) EU-Startups

Emulsion-based systems for fabrication of - researchgate.net

Emulsion-based systems for fabrication of researchgate.net

Get to know Singapore’s biopharmaceutical and biotechnology ecosystem - Home | JTC

Get to know Singapore’s biopharmaceutical and biotechnology ecosystem Home | JTC

Kelun-Biotech to out-license cancer immunotherapy A167 to Harbour BioMed - Pharmaceutical Business review -

Kelun-Biotech to out-license cancer immunotherapy A167 to Harbour BioMed Pharmaceutical Business review -

Adroit Biomed launches Glutone MD made from purest Setria Glutathione - Express Pharma

Adroit Biomed launches Glutone MD made from purest Setria Glutathione Express Pharma

Adroit Biomed launches Glutone Serum with advanced drone technology - Express Pharma

Adroit Biomed launches Glutone Serum with advanced drone technology Express Pharma

Top Biomed International Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant